Atlas Trials

Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus

Clinical trial NCT00614835 · COMPLETED

Trial details

NCT number
NCT00614835
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Uterine LeiomyosarcomaUterine Cancer
Start date
2001-08-01
Primary completion
2006-02-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.